Roche Holdings' Genentech is leading a study at 14 academic and community oncology centers to track genomic changes in patients undergoing treatment using Flatiron Health's IT platform to collect clinical, imaging and outcomes data on study participants and link it to genomic information from Foundation Medicine's liquid biopsy. If successful, the pilot study could streamline cancer research, the companies say.
Roche units partner on real-world data pilot study
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.